Walleye Capital LLC

Position in GSK — GSK plc

CIK 1758720 NEW YORK, NY

Back to GSK Full portfolio

Position in GSK

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$21,097,582

+$506,414 QoQ

Shares Held

402,472

+7.9% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#72

of 1,032 holders

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Derivatives in GSK

reported options exposure · as of Jun 30, 2026

CallValue

$5,247,242

CallShares

100,100

PutValue

$3,181,894

PutShares

60,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $213,456,876 across 14 Drug Manufacturers - General names. GSK ranks #4 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	240,318	$87,023,954
2	PFE	Pfizer Inc	2,417,136	$58,204,634
3	LLY	ELI LILLY & Co	28,457	$34,132,182
4	GSK	GSK plc This page	402,472	$21,097,582
5	NVO	Novo Nordisk A S	194,159	$9,307,982
6	SNY	Sanofi	33,051	$1,409,955
7	BMY	Bristol Myers Squibb Co	18,084	$1,042,000
8	JNJ	Johnson & Johnson	1,394	$354,034

All Filings in GSK

Export CSV

41 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,097,582	402,472	+7.9%	Shares	Sole	2026-08-03
2026-06-30	$5,247,242	100,100	-33.4%	Call	Sole	2026-08-03
2026-06-30	$3,181,894	60,700	-51.3%	Put	Sole	2026-08-03
2026-03-31	$6,882,193	124,700	-62.3%	Put	Sole	2026-05-13
2026-03-31	$20,591,168	373,096	+618.8%	Shares	Sole	2026-05-13
2026-03-31	$8,295,057	150,300	-40.1%	Call	Sole	2026-05-13
2025-12-31	$16,217,528	330,700	+331.7%	Put	Sole	2026-02-13
2025-12-31	$12,304,136	250,900	+139.0%	Call	Sole	2026-02-13
2025-12-31	$2,545,372	51,904	-70.1%	Shares	Sole	2026-02-13
2025-09-30	$3,306,056	76,600	+2.1%	Put	Sole	2025-11-14
2025-09-30	$4,531,800	105,000	+552.2%	Call	Sole	2025-11-14
2025-09-30	$7,504,531	173,877	+367.2%	Shares	Sole	2025-11-14
2025-06-30	$1,429,171	37,218	+79.2%	Shares	Sole	2025-08-13
2025-06-30	$618,240	16,100	-13.4%	Call	Sole	2025-08-13
2025-06-30	$2,880,000	75,000	+600.9%	Put	Sole	2025-08-13
2025-03-31	$720,564	18,600	-88.0%	Call	Sole	2025-05-14
2025-03-31	$804,668	20,771	-25.7%	Shares	Sole	2025-05-14
2025-03-31	$414,518	10,700	-51.1%	Put	Sole	2025-05-14
2024-12-31	$740,658	21,900	-82.6%	Put	Sole	2025-02-13
2024-12-31	$5,231,954	154,700	-28.9%	Call	Sole	2025-02-13
2024-12-31	$945,945	27,970	+201.6%	Shares	Sole	2025-02-13
2024-09-30	$5,159,056	126,200	+17.1%	Put	Sole	2024-11-14
2024-09-30	$379,121	9,274	-95.4%	Shares	Sole	2024-11-14
2024-09-30	$8,891,400	217,500	+34.5%	Call	Sole	2024-11-14
2024-06-30	$4,150,300	107,800	-60.4%	Put	Sole	2024-08-14
2024-06-30	$7,760,522	201,572	+10274.3%	Shares	Sole	2024-08-14
2024-06-30	$6,225,450	161,700	-27.3%	Call	Sole	2024-08-14
2024-03-31	$11,656,353	271,900	+131.2%	Put	Sole	2024-05-15
2024-03-31	$9,534,288	222,400	+315.7%	Call	Sole	2024-05-15
2024-03-31	$83,296	1,943	-90.4%	Shares	Sole	2024-05-15
2023-12-31	$749,242	20,217	—	Shares	Sole	2024-02-14
2023-12-31	$1,982,710	53,500	-0.6%	Call	Sole	2024-02-14
2023-12-31	$4,358,256	117,600	+12.5%	Put	Sole	2024-02-14
2023-09-30	$1,950,250	53,800	-17.7%	Call	Sole	2023-11-21
2023-09-30	$3,788,125	104,500	+40.3%	Put	Sole	2023-11-21
2023-06-30	$2,330,856	65,400	+121.7%	Call	Sole	2023-08-14
2023-06-30	$2,655,180	74,500	+72.1%	Put	Sole	2023-08-14
2023-03-31	$1,540,614	43,300	+566.2%	Put	Sole	2023-05-15
2023-03-31	$1,049,610	29,500	+49.0%	Call	Sole	2023-05-15
2022-09-30	$582,714	19,800	—	Call	Sole	2022-11-14
2022-09-30	$191,295	6,500	—	Put	Sole	2022-11-14
No filing history on record for this holder in this stock.